Varlitinib Completed Phase 2 Trials for Cancer of Stomach / Stomach Neoplasms / Neoplasm, Gastric / Cancer of the Stomach / Malignant Neoplasm of Stomach Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science2
clinicaltrials.gov IdentifierTitleDrugs
NCT01614522A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2